WBUR Staff

Richard Knox

Senior Correspondent, CommonHealth, WBUR

Richard Knox is an award-winning journalist who has reported on a broad range of topics in medicine, health, public and environmental health, global health, biomedical sciences, health economics and biomedical ethics. His reports — in print, on the air, and on the internet and social media — are known for incisiveness, authority and balance.

Knox has been a health and science correspondent for NPR and a medical writer for The Boston Globe. In addition to WBUR, his work appears in Goats and Soda, NPR’s global health and development blog, and NPR’s Facebook page. He’s the author of a respected book on Germany’s health system.

Knox has held year-long fellowships at Stanford and Harvard. He’s a graduate of the University of Illinois and Columbia University.

Recent stories

Asleep At The Wheel: Drowsy Driving As A Public Health Crisis

May 13, 2016
The National Highway Transportation Safety Administration says there were more than 72,000 documented accidents involving drowsy drivers between 2009 and 2013. But that’s just from official police reports, so experts say it’s a gross under-estimate. (Jesse Costa/WBUR)

The National Highway Transportation Safety Administration says there were more than 72,000 documented accidents involving drowsy drivers between 2009 and 2013. But that’s just from official police reports, so it’s a gross under-estimate.

Zika And Ebola Grab Headlines, But Lingering TB Worries Many In Public Health More

April 08, 2016

A new report finds that TB cases in the U.S. rose in 2015, after nearly 25 years of steady decline. The ancient scourge can still resurface, worrying some American public health specialists more than Zika or Ebola, and raising concerns about tight funding.

Researchers Use Big Data To Seek ‘Unique Fingerprint’ Of Long-Term Lyme Disease Symptoms

February 19, 2016
In this 2014 file photo, an informational card about ticks distributed by the Maine Medical Center Research Institute is seen in the woods in Freeport, Maine. (Robert F. Bukaty/AP)

Two new research projects employ Big Data to try to understand long-term symptoms of Lyme disease: One analyzes gene activity, and the other gathers self-reports from patients.

A $1 Pill That Could Save Thousands Of Lives: Research Suggests Cheap Way To Avoid U.N.-Caused Cholera

February 05, 2016

Researchers say a single U.N. peacekeeper may have introduced cholera to Haiti in 2010, touching off the most explosive cholera epidemic of modern times. New research says future tragedies could be largely avoided if peacekeepers took a $1 antibiotic pill before deployment. The U.N. has so far rejected that idea.

Zika Virus Prompts ‘Global Emergency,’ So Why Don’t U.S. Officials Sound Worried?

February 01, 2016

The World Health Organization declared a global health emergency in connection with birth defects believed to be linked to Zika virus, but the effects are expected to largely spare the mainland United States.

U.S. Health Care Is Less Private, More ‘Socialist’ Than You Might Think

January 22, 2016
Health care -- and the extent of the government's role in it -- have become a key issue in the Democratic presidential primary. Here, candidates Hillary Clinton and Bernie Sanders are seen in a debate on Jan. 17 in Charleston, S.C. (Mic Smith/AP)

A new study finds that 64.3 percent of U.S. health expenditures are government-financed.

Rare Common Ground: Gun Dealers And Public Health Workers Unite To Cut Suicides

January 15, 2016
(Image taken, with permission, from a New Hampshire Firearm Safety Coalition)

Specialists say there’s good reason to think point-of-sale prevention at gun shops can make a meaningful dent in curbing suicides.

Harvard Researchers: Make Police Killings A Matter Of Public Health

December 08, 2015

As numbers and news coverage of police killings mount, Harvard researchers say it’s time to take a public-health approach to the problem. They say public health departments should be tasked with compiling data on police killings the same way they do on infant mortality or drug overdose deaths.

U.S. Breast Cancer Deaths Falling Steadily — But Black Women Increasingly At Risk

October 30, 2015
Breast cancer is becoming an ever more-survivable disease, but there's bad news for African-Americans. Here a woman is screened in Los Angeles in 2010. (Damian Dovarganes/AP/File)

New research finds that breast cancer is becoming an increasingly survivable disease in the United States. But while the overall death rate has been dropping, the rate of getting cancer in the first place has been rising among African-American women.

Cancer Drug Mark-Ups: Year Of Gleevec Costs $159 To Make But Sells For $106K

September 25, 2015
A study finds that a year's supply of Gleevec , a leukemia drug, (generic name imatinib), costs about $159 a year to make, but the yearly price tag is $106,322 in the US and $31,867 in the UK. (Photo: Wikimedia Commons)

Amid much current discussion about high drug costs, a new study finds that the cost to make some commonly used cancer drugs is up to 600 times less than the sticker price.

Most Popular